IOL Chemicals Posts Strong Q2 Performance with Net Profit Surging Over 117% YoY
IOL Chemicals & Pharmaceuticals Ltd · Outcome · 30 Oct 2026, 11:32 pm
IOL Chemicals Posts Strong Q2 Performance with Net Profit Surging Over 117% YoY IOL Chemicals and Pharmaceuticals reported a 40.09% YoY increase in consolidated revenue from operations to ₹795.03 crore for the quarter ended 30th Sep'26, up from ₹567.53 crore in the corresponding prior-year period. Consolidated profit after tax jumped 117.12% YoY to ₹65.07 crore against ₹29.97 crore, driven by robust performance across segments. Pharmaceutical segment revenue rose 40.55% YoY to ₹472.75 crore, while Chemical segment revenue expanded 38.31% YoY to ₹394.49 crore. Diluted EPS for the quarter improved significantly to ₹2.22 from ₹1.02 YoY.
Original exchange filing (PDF)
More announcements from IOL Chemicals & Pharmaceuticals Ltd
- Clarification on increase in Volume · 11 Nov 2026
- The Exchange has sought clarification from IOL Chemicals & Pharmaceuticals Ltd on November 11, 2026, with reference to Movement in Volume. <BR><BR>The reply is awaited. · 11 Nov 2026
- Transcript of Earning Call on the Q2 & H1 FY27 Financial Results · 05 Nov 2026
- Audio Recording of Earnings Call on the Q2 & H1 FY 27 Financial Results · 02 Nov 2026
- Investor Presentation- Q2 & H1 FY27 · 02 Nov 2026
- Press Release · 31 Oct 2026
- Submission of Financial Results · 30 Oct 2026
- IOL Chemicals and Pharmaceuticals Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026. · 30 Oct 2026
